Esper Kallás

Specialty: Virology

Location: Global

Tier: UNRANKED

H-Index: 0

Years Active: 0

Hospital Affiliations

• University of São Paulo - Member

Key Publications

1. "Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women." - N Engl J Med (2021)
2. "Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults." - N Engl J Med (2024)
3. "Rapid viral metagenomics using SMART-9N amplification and nanopore sequencing." - Wellcome Open Res (2021)
4. "Preexposure chemoprophylaxis for HIV prevention in men who have sex with men." - N Engl J Med (2010)
5. "Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial." - Lancet HIV (2023)

Knowledge Graph Relationships

Esper Kallás is a Virology specialist affiliated with University of São Paulo. Authored 5 scholarly articles.